Get the Stockscreener App
4.39
1.13%
-0.05
After Hours:
4.35
-0.04
-0.91%
Neuronetics Inc stock is traded at $4.39, with a volume of 823.35K.
It is down -1.13% in the last 24 hours and up +25.79% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$4.44
Open:
$4.41
24h Volume:
823.35K
Relative Volume:
0.98
Market Cap:
$290.24M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-3.7203
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
-1.35%
1M Performance:
+25.79%
6M Performance:
+41.61%
1Y Performance:
+134.76%
1-Day Range:
$4.38
$4.69
1-Week Range:
$4.375
$4.8204
52-Week Range:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
4.39 | 293.55M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics Announces Positive Real-World Findings on NeuroStar TMS for Treating Depression in Adolescents and Young Adults - Quiver Quantitative
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents - Stock Titan
AI Trend Models Suggest Bounce for Neuronetics Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Neuronetics Inc. Price Targets Raised After ReboundLow Risk Swing Trade Opportunities Identified - metal.it
Short Covering May Lift Neuronetics Inc. in Near TermBreakout Momentum Picks With Protection Outlined - beatles.ru
Candlestick Reversal Detected on Neuronetics Inc.’s ChartWeekly Stock Watch With Growth Focus Expanded - metal.it
How strong is Neuronetics Inc. company’s balance sheetBuild wealth steadily with proven stock picks - jammulinksnews.com
What are Neuronetics Inc. company’s key revenue driversUnlock your portfolio’s full growth potential - jammulinksnews.com
Does Neuronetics Inc. stock perform well during market downturnsInvest confidently with real-time updates - jammulinksnews.com
Why is Neuronetics Inc. stock attracting strong analyst attentionBuild wealth steadily with expert advice - jammulinksnews.com
Is Neuronetics Inc. stock overvalued or undervaluedMaximize portfolio growth with expert advice - jammulinksnews.com
JMP reiterates Market Outperform rating on Neuronetics stock ahead of Q2 earnings - Investing.com Canada
When is Neuronetics Inc. stock expected to show significant growthRapid growth trajectories - jammulinksnews.com
What markets is HUBCZ expanding into Is Neuronetics Inc. stock a good long term investment optionAchieve breakthrough profits with expert advice - jammulinksnews.com
Intrinsic Value of Neuronetics Inc. Stock: Is It Undervalued or OvervaluedFree Access to Community - metal.it
How many analysts rate Neuronetics Inc. as a “Buy”Extraordinary market timing - jammulinksnews.com
What analysts say about Neuronetics Inc. stockHigh-octane investment gains - PrintWeekIndia
Neuronetics Inc. Stock Analysis and ForecastSuperior portfolio returns - PrintWeekIndia
What drives Neuronetics Inc. stock priceUnprecedented profit potential - PrintWeekIndia
When is the best time to buy Neuronetics Inc. stockDynamic capital growth - jammulinksnews.com
Is Neuronetics Inc. a good long term investmentExplosive capital appreciation - Autocar Professional
Neuronetics, Inc. (NASDAQ:STIM) Soars 29% But It's A Story Of Risk Vs Reward - 富途牛牛
Neuronetics to Announce Q2 2025 Results on August 5th - MSN
Neuronetics' (NASDAQ:STIM) growing losses don't faze investors as the stock hikes 13% this past week - simplywall.st
Unexpected Trends Reshaping the Transcranial Magnetic - openPR.com
Transcranial Magnetic Stimulation (TMS) Treatment Devices Market to Reach USD 2.61 Billion by 2034 - openPR.com
Neuronetics to Report Second Quarter 2025 Financial and Operatin - GuruFocus
Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times
Neuronetics Sets Q2 2025 Earnings Date: Leading Neurohealth Tech Company to Share Latest Financial Results - Stock Titan
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):